Danny Woo
Samson Wiseman
Preeti Viswanathan
Dr. Viswanathan received her Medical training at Kempegowda Institute of Medical Sciences in Bangalore, India. She then completed her Pediatric Residency at Miami Children?s Hospital and her fellowship at The Children?s Hospital at Montefiore. She has presented her research at national meetings and has received the Best Research Award at Pediatric Research Day Children?s Hospital at Montefiore 2011.
Mark I. Travin
Dr. Travin's <span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">clinical focus is on cardiac stress testing, radionuclide myocardial (perfusion and metabolic) imaging, and quantitative blood flow.</span><quillbot-extension-portal></quillbot-extension-portal>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Travin's research focus is on cardiac innervation radionuclide imaging with I-123 mIBG and analogous PET tracers, and quantitative blood flow assessment with myocardial perfusion PET.</span><quillbot-extension-portal></quillbot-extension-portal>
<p>Mark I. Travin, MD, FACC, MASNC, is Director of Cardiovascular Nuclear Medicine at Montefiore. He is also a Professor of Radiology and Medicine at our Albert Einstein College of Medicine. His clinical focus is on cardiac stress testing, radionuclide myocardial (perfusion and metabolic) imaging, and quantitative blood flow.</p><p>Dr. Travin earned his Bachelor of Science and Master of Science degrees in 1979 at Yale College, followed by his Doctor of Medicine degree in 1983 from the University of Pennsylvania School of Medicine. After graduating, he went on to complete both an internship and a residency in medicine at Lenox Hill Hospital. In 1986, Dr. Travin began a fellowship in cardiology at the Brown University Integrated Fellowship Program. After that, he went on to complete a clinical and research fellowship in medicine and cardiology, with emphasis in nuclear cardiology at Massachusetts General Hospital and Spaulding Rehabilitation Hospital. </p><p>Dr. Travin?s research focus is on cardiac innervation radionuclide imaging with I-123 mIBG and analogous PET tracers, and quantitative blood flow assessment with myocardial perfusion PET. He has a significant body of published research on cardiac imaging, and has received numerous awards and honors, including the Cardiology Program Director?s Training Award, and the American Society of Nuclear Cardiology 2015 Zaret-Beller Distinguished Journal of Nuclear Cardiology Service Award. </p>
Mark A. Thomas
Adit L. Tal
<p>Adit Tal, MD, is an Attending Physician at Children’s Hospital at Montefiore Einstein (CHAM) and an Assistant Professor of Pediatric Hematology, Oncology, Marrow and Blood Cell Transplantation at our Albert Einstein College of Medicine. Since joining the Montefiore team, Dr. Tal’s clinical focus has been the treatment of pediatric leukemia and lymphoma, and the supportive care of children with cancer.</p><p>Dr. Tal received her Bachelor of Arts in Neuroscience from Johns Hopkins University in 2008, followed by her Doctorate of Medicine at the Sackler School of Medicine. She began her postgraduate training in 2013 at CHAM and Albert Einstein College of Medicine, following her Pediatrics residency with a Pediatric Hematology/Oncology fellowship.</p><p>Building on her clinical practices, Dr. Tal’s research focuses on novel therapeutic targets for advanced treatments in metastatic osteosarcoma. She is examining a signaling pathway crucial to bone development and differentiation, and targeting this pathway to treat osteosarcoma. Her work has been published in numerous peer-reviewed articles.</p><p>Dr. Tal is board certified by the American Board of Pediatrics and is a member of many professional societies including the American Academy of Pediatrics, the Children’s Oncology Group, and the American Society of Clinical Oncology. She is also a member of the Professional Development Committee with the American Society of Pediatric Hematology/Oncology, and is a volunteer pediatric oncologist at Happiness Is Camping, a residential camp for children with cancer and their families.</p>
Michael L. Swerdlow
<p>Dr. Michael Swerdlow graduated from The University Of Pennsylvania School of Medicine. He did a medical residency at Mt. Sinai Hospital in New York. He then completed the neurology residency at Albert Einstein College of Medicine in The Bronx. He then did a fellowship Neuromuscular diseases at the N.I.H. in Bethesda. He joined the faculty at Montefiore Hospital and Albert Einstein College. He presently is a Professor of Clinical Neurology. He has a large faculty practice with Dr. David Kaufman as "K and S." He teaches residents and supervises the Neurology Clinic and is involved in CME teaching. Special areas of interest include muscle disorders, Myasthenia Gravis, Multiple Sclerosis and disorders of the spine.</p>
Michael B. Stemerman
<p>Most people in the USA die of cardiovascular disease. A major risk factor for heart attacks is elevated cholesterol, especially the cholesterol carried by low density lipoprotein (LDL). Our studies examine the hypothesis that LDL alters the function of the vascular endothelium and this alteration may be an important mechanism for the development of atherosclerosis. Of particular focus is our understanding of the molecular mechanisms involved in this process and the role mononuclear cells play in their interaction with the LDL treated vascular endothelium.</p>
<p><a target="_blank" href="http://biomed.ucr.edu/content/view/69/66/">Dr. Stemerman's Laboratory and Researchers</a></p>
<p>Liu, Y., Chen, B.P., Lu, M., Zhu, Y., Stemerman, M.B., Chien, S. and Shyy, J.Y. 2002. Shear stress activation of SREBP1 in endothelial cells is mediated by integrins. Arterioscler. Thromb. Vasc. Biol. 22: 76-81.<br />
<br />
Yuan, Y., Verna, L.K., Wang, N.P., Liao, H.L., Ma, K.S., Wang, Y., Zhu, Y. and Stemerman M.B. 2001. Cholesterol enrichment upregulates intercellular adhesion molecule-1 in human vascular endothelial cells. Biochim. Biophys. Acta. 1534: 139-48.<br />
<br />
Wang, N., Verna, L., Liao, H.L., Ballard, A., Zhu, Y. and Stemerman, M.B. 2001. Adenovirus-mediated overexpression of dominant-negative mutant of c-Jun prevents intercellular adhesion molecule-1 induction by LDL: a critical role for activator protein-1 in endothelial activation. Arterioscler. Thromb. Vasc. Biol. 21: 1414-20.<br />
<br />
Wang, N. and Stemerman, M.B. 2001. Ref-1 and transcriptional control of endothelial apoptosis. Circulation Res. 88: 1223-1225.<br />
<br />
Zhu, Y., Liao, H-L, Wang, N., Ma, K-S., Verna, L.K., Shyy, Y-J., Chien, S. and Stemerman, M.B. 2001. LDL-Activated p38 in Endothelial Cells is Mediated by Ras. Arteriosclerosis Thromb. Vasc. Biol. 21: 1159-1164.<br />
<br />
Stemerman, M.B. 2000. Lipoprotein effects on the vessel wall. Circ. Res. 86: 715-716. Review<br />
<br />
Liao, H.L., Zhu, Y., Wang, N., Verna, L. and Stemerman, M.B. 2000. Selective activation of endothelial cells by the antioxidant pyrrolidine dithiocarbamate: involvement of c-Jun and Jun N-terminal kinase activation. Endothelium 7: 121-33.<br />
<br />
Wang, N., Verna, L., Hardy, S., Zhu, Y., Ma, K-S., Birrer, M.J. and Stemerman, M.B. 1999. c-Jun triggers apoptosis in human vascular endothelial cells. Circ. Res. 85: 387-393.<br />
<br />
Wang, N.P., Verna, L., Hardy, S., Forsayeth, J., Zhu, Y. and Stemerman, M.B. 1999. Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells. Arterio. Thromb. Vasc. Biol. 19: 2078-2084.<br />
<br />
Zhu, Y., Liao, H.L., Lin, H.-C., Verna, L. and Stemerman, M.B. 1999. Low-density lipoprotein augments interleukin-1-induced vascular adhesion molecule expression in human endothelial cells. Atherosclerosis 144: 357-365.<br />
<br />
Zhu, Y., Liao, H.L., Wang, N.P., Friedli, O., Verna, L. and Stemerman, M.B. 1999. Low density lipoprotein activates Jun N-terminal kinase (JNK) in human endothelial cells. Biochimica et Biophysica Acta 1436: 557-564.<br />
<br />
Zhu, Y., Lin, J.H.C., Liao, H.-L., Friedli, O., Verna, L., Marten, N.W., Straus, D.S. and Stemerman, M.B. 1998. Low-density lipoprotein induces transcription factor activator protein-1 (AP-1) in human endothelial cells. Arterio. Thromb. Vasc. Biol. 18: 473-470.<br />
<br />
Zhu, Y., Lin, H.-C., Liao, H.L., Verna, L. and Stemerman, M.B. 1997. Activation of ICAM-1 promoter by lysophosphatidylcholine: Possible involvement of protein tyrosine kinases. Biochimica et Biophysica Acta 1345: 93-98.</p>
Martina Stehlikova
<p>In-patient internal medicine with a special interest in hematology. Anemia, thrombocytopenia and coagulopathy in hospitalised patients.</p>